Thailand aims to vaccinate up to half of its population against Covid-19 next year according to the director of its National Vaccine Institute, Dr. Nakorn Premsri.

Dr Nakorn Premsri said AstraZeneca, a British-Swedish pharmaceutical company, will produce 200 million doses of its anti-coronavirus vaccine in Thailand next year with the help of Siam Bioscience.

Besides supplying the vaccine to Thailand, AstraZeneca will also support the local mass production of the doses by Siam Bioscience.

The number of doses to be supplied to Thailand was not disclosed, but Prime Minister Prayut Chan-o-cha said last week that the contract was for the purchase of 26 million doses, enough for 13 million people, as each person needs two shots.

Thailand’s Public Health Ministry and the local conglomerate SCG, with its packaging and chemicals divisions, also joined the 200 million doses order stating that most of the doses would head abroad.

“Thailand will secure only 26 million doses. We may ask for more, but it will not be a big part, so maybe more than half of that [200 million] can be exported,” he told VOA.

“It’s in the letter of intent that we made together with Siam Bioscience, AstraZeneca, SCG and Ministry of Public Health that it will be distributed within the ASEAN region,” he added, referring to the 10-member Association of Southeast Asian Nations.

However, Nakorn Premsri told the Financial Time that Thailand was also in talks with other parties, including producers in China, Russia and India, for the possible import of other vaccines.

By today (as of 23rd of December), around 5,762 such cases have been confirmed in Thailand. Over 3,095 patients have recovered and 60 patients have died. An emergency regime will stay in place until January 15, 2021.

About the author

Bangkok Correspondent at Siam News Network

Bangkok Correspondent for Siam News Network. Editor at Thailand Business News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Sign Up for Our Newsletter

Get notified of our weekly selection of news

You May Also Like

Thailand quarantines 12 crew members and passengers on Monkeypox alert

The 12 crew members and passengers on the same flight, who were in close contact with the infected traveller, have now been quarantined in Thailand for seven days.

APAC region records 119% QoQ growth in M&A deal value in Q2 2022

India, Australia and China were the top three countries when measured in terms of M&A deal value in Q2, with India accounting for half of the top 20 deals. South Korea, Indonesia, Malaysia, and Japan were the next top countries that contributed to a surge in M&A deal value.

Asia-Pacific: Companies face rising credit risks despite shorter payment delays

Coface’s 2022 Asia Corporate Payment Survey, conducted between November 2021 and February 2022, provides insights into the evolution of payment behaviour and credit management practices of about 2,800 companies across the Asia Pacific region during another pandemic year.